Use of Oral Anticoagulation among Stroke Patients with Atrial Fibrillation in China: The ChinaQUEST (Quality Evaluation of Stroke Care and Treatment) Registry Study
Authors:
- Craig S. AndersonCACraig S. Anderson
- Ka Sing WongKWKa Sing Wong
- for the China QUEST Study InvestigatorsFIfor the China QUEST Study Investigators
- 14 December 2011
- journal article
- research article
- Published by SAGE Publications in International Journal of Stroke
- Vol. 8 (3) , 150-154
Abstract
Background: International guidelines recommend oral anticoagulation in patients with atrial fibrillation according to their level of stroke risk. This study aimed to determine oral anticoagulation use in atrial fibrillation patients with recent ischemic stroke and examine factors that impact such management in China. Methods: Among the patients with acute ischemic stroke ( n = 4782) from the China QUality Evaluation of Stroke Care and Treatment study, a multicenter, prospective, 62-hospital registry in China, there were 499 (10%) (mean age 70 ± 12 years, 49% female) with documented atrial fibrillation with outcome data over 12 months of follow-up. Logistic regression analysis was used to identify the independent predictors of oral anticoagulation use in these patients. Results: Of the 499 stroke patients with atrial fibrillation, oral anticoagulation use was 20% overall but varied from 8% prestroke and 11% in-hospital (poststroke), to 13% and 10% at three-months and 12 months, respectively. Oral anticoagulation use was independently associated with younger age (odds ratio 0·95, 95% confidence interval 0·93–0·97, P < 0·001), nonmanual occupation (odds ratio 0·44, 95% confidence interval 0·25–0·80, P = 0·006), and less cardiovascular risk factors (odds ratio 0·81, 95% confidence interval 0·68–0·96, P = 002). Conclusions: These data indicate oral anticoagulation use is lower in stroke patients with atrial fibrillation in China than that in Western countries, being applied more often in those of younger age, nonmanual occupation, and having less cardiovascular risk factors.Keywords
This publication has 15 references indexed in Scilit:
- Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?The American Journal of Medicine, 2010
- Impact of Prestroke Oral Anticoagulation on Severity and Outcome of Ischemic and Hemorrhagic Stroke in Patients with Atrial FibrillationCerebrovascular Diseases, 2010
- Oral Anticoagulation in Nonvalvular Atrial Fibrillation in Clinical Practice: Impact of CHADS2 Score on OutcomeCardiology, 2010
- Relation of Effective Anticoagulation in Patients With Atrial Fibrillation to Stroke Severity and Survival (from the National Acute Stroke Israeli Survey [NASIS])The American Journal of Cardiology, 2010
- Prevention of Stroke in Patients with High-Risk Atrial FibrillationCurrent Neurology and Neuroscience Reports, 2010
- Sex-Related Differences in the Risk Factor Profile and Medications of Patients With Atrial Fibrillation Recruited in J-TRACECirculation Journal, 2010
- Reasons for Undertreatment with Oral Anticoagulants in Frail Geriatric Outpatients with Atrial FibrillationDrugs & Aging, 2010
- Role of Health Insurance in Averting Economic Hardship in Families After Acute Stroke in ChinaStroke, 2009
- Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trialThe Lancet, 2007
- Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial FibrillationCirculation, 2007